The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(3-(4-benzyl-1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)phenoxy)-2-methylpropanoic acid ID: ALA4877444
PubChem CID: 137544893
Max Phase: Preclinical
Molecular Formula: C30H33N3O4
Molecular Weight: 499.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)n(Cc3ccccc3)c2=O)cc1
Standard InChI: InChI=1S/C30H33N3O4/c1-22-12-14-25(15-13-22)21-33-29(36)32(20-24-8-5-4-6-9-24)27(31-33)11-7-10-23-16-18-26(19-17-23)37-30(2,3)28(34)35/h4-6,8-9,12-19H,7,10-11,20-21H2,1-3H3,(H,34,35)
Standard InChI Key: JEGVTIYREHRTLH-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
33.5517 -5.6920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1434 -4.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7305 -5.6893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2876 -4.9919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2865 -5.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0013 -6.2322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7178 -5.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7149 -4.9883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9995 -4.5791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4279 -4.5730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8569 -4.5677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5730 -4.9775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8538 -3.7426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5716 -6.2313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8574 -5.8182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1426 -6.2301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4284 -5.8171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3430 -4.9988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.5361 -4.8265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1230 -5.5408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6746 -6.1543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3025 -5.6264 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5036 -6.9613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7190 -7.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2011 -4.0726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6867 -3.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5066 -3.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9919 -2.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6569 -2.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8319 -1.9911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3503 -2.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1103 -6.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3264 -6.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1547 -7.7267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7730 -8.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5546 -8.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1415 -1.4081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
11 13 1 0
5 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 1 0
20 22 2 0
21 23 1 0
23 24 1 0
19 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
24 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 24 1 0
29 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 499.61Molecular Weight (Monoisotopic): 499.2471AlogP: 4.87#Rotatable Bonds: 11Polar Surface Area: 86.35Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.87CX Basic pKa: ┄CX LogP: 6.90CX LogD: 3.66Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.32Np Likeness Score: -0.87
References 1. Yu DD, Van Citters G, Li H, Stoltz BM, Forman BM.. (2021) Discovery of novel modulators for the PPARα (peroxisome proliferator activated receptor α): Potential therapies for nonalcoholic fatty liver disease., 41 [PMID:34022528 ] [10.1016/j.bmc.2021.116193 ]